2016 Volume 27 Issue 3 Pages 317-322
Twenty eight patients (mean age, 43 years) with venous malformation in the limbs were underwent foam sclerothrapy at our clinic. Foam sclerosant was made by 0.5‒3.0% polidocanol with the mixing ratio of 1 + 5 for sclerosant plus air and injected up to the maximum dose of 10 ml per treatment session. Compression stockings or sleeve applied after sclerotherapy for three weeks in the lower limb, one week in the upper limb. We treated 19 venous malformation (7 upper limb, 12 lower limb) and 9 Klippel-Trenaunay syndrome. A total of 92 treatment sessions were performed (mean, 3.3 sessions per patient). Concentrations of polidocanol were 0.5% in 19 sessions, 1% in 39 sessions, and 3% in 34 sessions. Average foam volumes injected per treatment session was 8.6 ml (range: 2‒10 ml). The overall outcome was good in 10 (36%), fair in 12 (43%), and poor in 6 (21%). No serious complications were shown except one case with superficial thrombophlebitis. Polidocanol foam sclerotherapy is a safe and effective treatment method for venous malformation in the limbs.
